TGTX
Tg Therapeutics
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: TGTX
- PE Ratio
As of Jun 3, 2026, the Tg Therapeutics stock's price-to-earnings ratio is 12.46. This results from the current EPS of $3.22 and stock price of $40.11. The PE ratio has decreased by 58% from the past four quarters average of 29.9.
TGTX PE ratio history
The PE ratio of Tg Therapeutics has averaged 80.23 over the last three years. The current P/E ratio of 12.46 is 84% lower than the historical average. In the past three years, TGTX's PE ratio peaked in the Dec 2023 quarter at 189.78, when the stock price was $17.08 and the EPS was $0.09. The lowest point was in the Dec 2025 quarter, when it reached 9.62 with a price of $29.81 and an EPS of $3.1.
Tg Therapeutics PE ratio by year
Maximum annual decrease: -94.89% in 2025
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 9.62 | -94.89% | $29.81 | $3.1 |
| 2024 | 188.13 | -0.87% | $30.1 | $0.16 |
| 2023 | 189.78 | N/A | $17.08 | $0.09 |
| 2022 | N/A | N/A | $11.83 | -$1.65 |
| 2021 | N/A | N/A | $19 | -$2.63 |
| 2020 | N/A | N/A | $52.02 | -$2.42 |
| 2019 | N/A | N/A | $11.1 | -$1.96 |
| 2018 | N/A | N/A | $4.1 | -$2.3 |
| 2017 | N/A | N/A | $8.2 | -$1.91 |
| 2016 | N/A | N/A | $4.65 | -$1.6 |
| 2015 | N/A | N/A | $11.93 | -$1.38 |
| 2014 | N/A | N/A | $15.84 | -$1.64 |
| 2013 | N/A | N/A | $3.9 | -$0.81 |
| 2012 | N/A | N/A | $3.64 | -$1.38 |
| 2011 | N/A | N/A | $1.14 | -$0.44 |
Tg Therapeutics PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 10.32 | 7.28% | $33.22 | $3.22 |
| Dec 2025 | 9.62 | -18.27% | $29.81 | $3.1 |
| Sep 2025 | 11.77 | -86.59% | $36.13 | $3.07 |
| Jun 2025 | 87.78 | -39.89% | $35.99 | $0.41 |
| Mar 2025 | 146.04 | -22.37% | $39.43 | $0.27 |
| Dec 2024 | 188.13 | N/A | $30.1 | $0.16 |
| Sep 2024 | N/A | N/A | $23.39 | -$0.09 |
| Jun 2024 | 26.16 | -50.12% | $17.79 | $0.68 |
| Mar 2024 | 52.45 | -72.36% | $15.21 | $0.29 |
| Dec 2023 | 189.78 | N/A | $17.08 | $0.09 |
| Sep 2023 | N/A | N/A | $8.36 | -$0.39 |
| Jun 2023 | N/A | N/A | $24.84 | -$1.45 |
| Mar 2023 | N/A | N/A | $15.04 | -$1.41 |
| Dec 2022 | N/A | N/A | $11.83 | -$1.65 |
| Sep 2022 | N/A | N/A | $5.92 | -$1.77 |
TGTX Price vs fair value
TGTX average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
The current PE ratio of TGTX is lower than the 3, 5 and 10-year averages.
PE comparison
With a P/E of 12.46, TGTX stands below the Healthcare sector and the industry average. In comparison with its Healthcare sector average of 23.02, Tg Therapeutics's P/E is 46% lower.
TGTX PE vs peers
TGTX's PE ratio stands lower than its peer stock ALKS.
| Stock name | PE ratio | Market cap |
|---|---|---|
| TGTX Tg Therapeutics Inc | 12.59 | $6.21B |
| ALKS Alkermes plc | 46.63 | $7.23B |
| NERV Minerva Neurosciences Inc | N/A | $222.69M |
Frequently asked questions
What is Tg Therapeutics's PE ratio?
The price to earnings ratio for TGTX stock as of Jun 3, 2026, stands at 12.46.
What is the 3-year average PE ratio for Tg Therapeutics (TGTX)?
The 3-year average price to earnings ratio for TGTX stock is 80.23.
What is the 5-year average PE ratio for Tg Therapeutics (TGTX)?
The 5-year average price to earnings ratio for TGTX stock is 80.23.
What is the highest PE ratio for TGTX?
The highest quarterly PE ratio in the last three years has been 189.78 and it was in the Dec 2023 quarter.
How does the current PE ratio for TGTX compare to its historical average?
TGTX's price to earnings ratio is currently 84% below its 3-year historical average.
How is TGTX's PE ratio calculated (Tg Therapeutics PE ratio formula)?
The P/E ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Jun 3, 2026), Tg Therapeutics's stock price is $40.11. The earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $3.22. Therefore, Tg Therapeutics's PE ratio for today is 12.46. PE RATIO(12.46) = STOCK PRICE($40.11) / TTM EPS($3.22)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.